Stay updated on Nivolumab Plus Ipilimumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in Melanoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now shows Revision: v3.3.4, replacing the previous v3.3.3, which is a minor update with no visible impact on study content or functionality — To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:39:32.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Added new Locations and regional entries (Australian Capital Territory, New South Wales, Northern Territory, Queensland, South Australia, Tasmania, Victoria, Western Australia, Rhineland-palladium, Greater London, Tyne and Wear) to the study page. Removed HHS Vulnerability Disclosure, Melanoma, MedlinePlus Genetics, and several location groupings (Australian Capital Territory Locations, New South Wales Locations, Northern Territory Locations, Queensland Locations, South Australia Locations, Tasmania Locations, Victoria Locations, Western Australia Locations, Rhineland-palladium Locations, Greater London Locations, Tyne and Wear Locations) with an updated revision tag.
    Difference
    0.7%
    Check dated 2025-12-23T22:50:29.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Added Melanoma to related topics and a Related Topics link to MedlinePlus Genetics on the Study Details page. These are minor contextual enhancements that do not change the primary trial information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-09T19:38:12.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Publications section now states that PubMed-derived publications are automatically filled from PubMed, and the page revision is updated to v3.3.2, with related-topic wording removed.
    Difference
    0.1%
    Check dated 2025-11-25T12:01:04.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Added Melanoma and related topics: MedlinePlus Genetics; removed government funding lapse notice on NIH operations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T07:21:13.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    The related topics section no longer lists Melanoma and MedlinePlus Genetics.
    Difference
    0.1%
    Check dated 2025-11-11T03:09:03.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Melanoma Clinical Trial page.